ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00092287
Recruitment Status : Terminated
First Posted : September 27, 2004
Last Update Posted : February 27, 2008
Sponsor:
Information provided by:
Ipsen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : October 2004